Abstract:Ji Guo, 1– 3 Shengqi Yang, 1– 4 Weifeng Zhai, 1– 3, 5 Yue Xie, 1– 4 Zhan Shen, 1– 4 Jianpo Zhang, 1– 3 Yongwei Jia 1– 3, 5 1 Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200052, People's Republic of China; 2 Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, 200052, People's Republic of China; 3 Institute of Arthritis Research in Integrative Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 200052, People's Republic of China; 4 Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China; 5 Department of Orthopedics, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, 201318, People's Republic of China Correspondence: Ji Guo; Yongwei Jia, Email ; Background: Intervertebral disc degeneration (IVDD) is a pathophysiological process that leads to severe back pain or neurological deficits. The Bushen Huoxue Formula (BSHXF) is a traditional herbal remedy widely used to treat diseases related to IVDD. However, its pharmacological mechanism needs further exploration. Objective: This study aimed to elucidate the mechanisms through which BSHXF treats IVDD-related diseases by integrating metabolomics with network pharmacology. Methods: Network pharmacology was utilized to identify potential targets of BSHXF against IVDD. Additionally, an animal model of needle puncture-induced disc degeneration was established to assess the effect of BSHXF. Mice were randomly assigned to the sham group, model group, and BSHXF group. Various techniques, including PCR, CCK-8 assay, MRI, histological examinations, and immunohistochemical analyses, were employed to evaluate degenerative and oxidative stress conditions in mouse disc tissue and cultured nucleus pulposus (NP) cells. UHPLC-HRMS/MS was used to differential distinct metabolites in the disc tissue from different groups, and MetaboAnalyst 5.0 was employed to enrich the metabolic pathways. Results: Through network pharmacology, 15 core proteins were identified through protein-protein interaction (PPI) network construction. Functional enrichment analysis highlighted the critical role of BSHXF in addressing IVDD by influencing the response to oxidative stress. Furthermore, experimental evidence demonstrated that BSHXF significantly improved the pathological progression of IVDD and increased oxidative stress markers SOD-1 and GPX1, both in the disc degeneration model and cultured NP cells. Metabolomics identified differential metabolites among the three groups, revealing 15 metabolic pathways between the sham and model groups, and 13 metabolic pathways enriched between the model and BSHXF groups. Conclusion: This study, integrating network pharmacology and metabolomics, suggests that BSHXF can alleviate IVDD progression by modulating oxidative stress. Key metabolic pathways associated with BSHXF-mediated reduction of oxidative stress include the citrate cycle, cysteine and methionine metabolism, alanine, aspartate and glutamate metabolism, glycine, serine and threonine metabolism, D-glutamine and D-glutamate metabolism, glutathione metabolism, and tryptophan metabolism. While this research demonstrates the therapeutic potential of BSHXF in reducing oxidative stress levels in IVDD, further research is needed to thoroughly understand its underlying mechanisms. Keywords: metabolomics, network pharmacology, intervertebral disc degeneration, oxidative stress, Bushen Huoxue formula Intervertebral disc degeneration (IVDD) is a multifaceted pathophysiological process involving genetic, mechanical, immune, and metabolic factors. Its pathological changes manifest through a reduction in nucleus pulposus (NP) cell quantity, diminished proliferation activity, and reduced extracellular matrix synthesis. 1,2 IVDD stands as a major contributor to lower back pain, often culminating in disc herniation, spinal stenosis, and other degenerative disc conditions, profoundly impacting patients' quality of life and productivity and imposing a significant socioeconomic burden. Current clinical approaches for IVDD primarily focus on symptom alleviation, predominantly employing nonsteroidal anti-inflammatory drugs (NSAIDs). 3,4 However, both conservative and surgical treatments fall short of completely reversing IVDD's pathological changes. 5 Traditional Chinese medicine (TCM) is characterized by its "multi-component, multichannel" nature, rendering it well-suited for personalized treatment and early intervention. 6 TCM philosophy emphasizes -Abstract Truncated-

Bu Shen Huo Xue Formula Provides Neuroprotection Against Spinal Cord Injury by Inhibits Oxidative Stress by Activating the Nrf2 Signaling Pathway

Resveratrol Treatment of Spinal Cord Injury in Rat Model.

Hydrogen Sulfide Ameliorates Blood-Spinal Cord Barrier Disruption and Improves Functional Recovery by Inhibiting Endoplasmic Reticulum Stress-Dependent Autophagy.

Beneficial Effect of the Traditional Chinese Drug Shu-Xue-Tong on Recovery of Spinal Cord Injury in the Rat

Network Pharmacology with Metabolomics Study to Reveal the Mechanisms of Bushen Huoxue Formula in Intervertebral Disc Degeneration Treatment

Dl-3-n-butylphthalide Prevents the Disruption of Blood-Spinal Cord Barrier Via Inhibiting Endoplasmic Reticulum Stress Following Spinal Cord Injury

Treatment with 2-BFI Attenuated Spinal Cord Injury by Inhibiting Oxidative Stress and Neuronal Apoptosis Via the Nrf2 Signaling Pathway

Dddt_a_209636 3693..3704

Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury

Notoginsenoside R1 Alleviates Spinal Cord Injury by Inhibiting Oxidative Stress, Neuronal Apoptosis, and Inflammation via Activating the Nrf2/HO-1 Signaling Pathway

Traditional Chinese Medicine formula Bu-Shen-Huo-Xue-Fang (BSHXF) protects nucleus pulposus cells against the inflammatory and oxidative stress-induced degenerative changes

Elucidation of the mechanism of Zhenbao pills for the treatment of spinal cord injury by network pharmacology and molecular docking: A review

Tert-butylhydroquinone Protects the Spinal Cord Against Inflammatory Response Produced by Spinal Cord Injury.

An antioxidative sophora exosome-encapsulated hydrogel promotes spinal cord repair by regulating oxidative stress microenvironment

Hydrogen Sulfide can Scavenge Free Radicals to Improve Spinal Cord Injury by Inhibiting the p38MAPK/mTOR/NF-κB Signaling Pathway

Neuroprotective Effects Of Diosgenin In Rats With Experimental Spinal Cord Injury Via Promotion Of Autophagy

Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury

Oxidative stress following spinal cord injury: From molecular mechanisms to therapeutic targets

Coenzyme Q10 Suppresses Oxidative Stress and Apoptosis Via Activating the Nrf-2/NQO-1 and NF-κB Signaling Pathway after Spinal Cord Injury in Rats.

Sodium Tanshinone IIA Sulfonate Promotes Spinal Cord Injury Repair by Inhibiting Blood Spinal Cord Barrier Disruption in Vitro and in Vivo.

Geniposide Protects Against Spinal Cord Injury In Rats Through Attenuating The Regulation Of Inflammatory Response And The Bcl2/Bax Pathway